SEC Company Response from Evolent Health, Inc. (EVH) (CIK 0001628908) (EVH) — Jun 2, 2015
Evolent Health, Inc. (EVH) (CIK 0001628908)
Date: June 2, 2015 · CIK: 0001628908 · Accession: 0001193125-15-210290
AI Filing Summary & Sentiment
File numbers found in text: 333-203852
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Evolent Health, Inc. Registration Statement on Form S-1 File No. 333-203852 June 2, 2015
Dear Ms. Gowetski:
Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), Evolent Health, Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that the Registration Statement, as then amended, will become effective under the Securities Act by 3:30 p.m. (Washington, D.C. time) on June 4, 2015, or as soon thereafter as practicable.
In connection with this request, the Company acknowledges that:
•
should the Commission or the staff of the Commission (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
•
the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
•
the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform William V. Fogg at (212) 474-1131 and then send written confirmation to the addressees listed on the cover of the Registration Statement.
Very truly yours,
Evolent Health, Inc.
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request Evolent Health, Inc. 800 N. Glebe Road, Suite 500 Arlington, VA 22203 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-7010 Attn: Ms. Jennifer Gowetski Mr. Rahul Patel Mr. Howard Efron Mr. Robert Telewicz Evolent Health, Inc. Registration Statement on Form S-1 File No. 333-203852 June 2, 2015 Dear Ms. Gowetski: Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), Evolent Health, Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that the Registration Statement, as then amended, will become effective under the Securities Act by 3:30 p.m. (Washington, D.C. time) on June 4, 2015, or as soon thereafter as practicable. In connection with this request, the Company acknowledges that: • should the Commission or the staff of the Commission (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; • the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and • the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. It would be appreciated if, as soon as the Registration Statement is declared effective, you would so inform William V. Fogg at (212) 474-1131 and then send written confirmation to the addressees listed on the cover of the Registration Statement. Very truly yours, Evolent Health, Inc. By: /s/ Jonathan Weinberg Name: Jonathan Weinberg Title: General Counsel